Government
Every published round Federal BioMedTech Horizons Program took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Everyone Federal BioMedTech Horizons Program has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
Companies Federal BioMedTech Horizons Program has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Federal BioMedTech Horizons Program, as distinct from the investments it has made.
Companies Federal BioMedTech Horizons Program has backed that another company then bought. An exit for the holding, not a deal Federal BioMedTech Horizons Program did.
Stories naming Federal BioMedTech Horizons Program. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Diagnostics firm Zip Diagnostics received a $600,000 federal grant through the BioMedTech Horizons program to commercialise rapid Covid-19 tests built on Axxin platforms.
Cancer-detection nanotech developer Ferronova announced a $3.5 million Series A round, with Uniseed leading, to fund planned human trials across several cancer types; research partners span four universities.